electrical field in injured tissue; and provides electrochemical information, which modulates relevant biochemical pathways. The company’s tPEMF signals are used to enhance the specific physiological processes, including that generate the body's natural anti-inflammatory response and tissue repair. Its products include SofPulse M-10, Roma, and Torino PEMF products that utilize tPEMF technology to treat edema and pain in soft tissue. The company’s products consist of three components: tPEMF signal, signal generator, and applicators. The signal generator produces a specific tPEMF signal that is pulsed through the applicator. The applicator transmits the tPEMF signal into the soft tissue target, penetrating medical dressings, casts, coverings, clothing, and other non-metal materials. Its products are used for the treatment of acute or chronic wounds, including serious trauma wounds, failed surgical closures, amputations, pressure ulcers, and post surgical wounds; edema and pain following plastic and reconstructive surgery procedures; and pain associated with the inflammatory phase of chronic conditions. Ivivi Technologies, Inc. sells and rents its products to nursing facilities, rehabilitation hospitals, acute care hospitals and facilities, and home health care systems through third-party distributors, contract therapy service companies in the United States, Canada, and the European Union. Ivivi Technologies, Inc. was founded in 1989 and is headquartered in Montvale, New Jersey.